9 Meters Biopharma, Inc. NMTR 0.09 9 Meters Biopharma, Inc.

Home
⇒ 
Stock List ⇒ 9 Meters Biopharma, Inc.
Range:0.0715-6.56Vol Avg:446108Last Div:0Changes:-0.05
Beta:1.48Cap:0.00BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Mon Jul 11 2016Empoloyees:10
CUSIP:654405109CIK:0001551986ISIN:US6544052086Country:US
CEO:Ms. Bethany Sensenig C.M.A., M.B.A.Website:https://www.9meters.com
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow